TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Harris Hip Score (HHS) for activity and range of motion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Myoglobin blood levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Concentrations of low density lipoprotein cholesterol
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Concentrations of apolipoprotein B
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Myocardial Salvage Index (MSI) at 3 months after pPCI
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Performance on the AX continuous performance test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prepulse inhibition (PPI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: SRS (Sedation Recovery Score)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Rates of stroke, TIA, or deep vein thrombosis
Endpoint domain: Mortality/survival
Primary endpoint: Rates of myocardial infarction or ischemia
Endpoint domain: Mortality/survival
Primary endpoint: Prevention of heartburn
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Reduction in severity of heartburn-related symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Conversion to NSR within 8h after onset of AF
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Improvement in IRLS score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction of PLM index
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in sleep architecture
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: unnecessary admissions
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Systemic lupus erythematosus disease activity index (SLEDAI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Dose of prednisone used
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: postoperative hemoglobin values
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: total packed red cells per patient
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: mean percentage reduction in overall acne severity score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: EQ-5D-3L Index score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Lund-Kennedy scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Chronic enteritis development
Endpoint domain: Adverse events/effects
Primary endpoint: Health-related quality of life (SF-36 Total score)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Serum amylase ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Serum lipase ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: overall success as estimated by life table analysis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 6% weight loss achievement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: total weight self-efficacy score improvement
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Overall severity of cannabis withdrawal
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: binge-free days
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: total societal costs
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Frequency of stuttering
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cognitive performance in block design test
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Cognitive performance in visual recognition test
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Cognitive performance in digit-symbol substitution test
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Wrong reactions in choice reaction test
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Mucosal concentrations of mesalazine in the rectum
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Mucosal concentrations of mesalazine in the descending colon
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: cartilage volume loss in the medial compartment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: early diagnostic awareness of dementia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Median duration of pain control
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ED50 of ropivacaine required to initiate epidural analgesia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Carriage of vaccine-type pneumococci
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Fever after dose 1
Endpoint domain: Adverse events/effects
Primary endpoint: Antibody concentrations of > or =0.35 microg/mL
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Dependence on refractive correction
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Hyperaemic adenosine stimulated flow
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Adherence to nutrition recommendations
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Adherence to walking intervention
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Reduction in quantitative biofilm‐protected bacteria
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: facial erythema associated with rosacea
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: PICP to ICTP ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: MMP‐9 concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: TIMP‐1 concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sensitivity for detection of AMI
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Specificity for detection of AMI
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: clinical composite response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Blood pressure variations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Percent weight loss at 4 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CRC screening participation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Advanced adenoma detection rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: one-repetition maximum strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: appendicular skeletal muscle mass
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Postoperative hospital opioid use
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Narcotic consumption at home
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Global Rating Scale (GRS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pediatric appointment retention
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Intraoperative bleeding requiring blood transfusions
Endpoint domain: Adverse events/effects
Primary endpoint: 1-year overall survival (OS) rate
Endpoint domain: Mortality/survival
Primary endpoint: composite endpoint of optimal medical therapy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Recurrent epiphora
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Average final surface area of the osteotomy opening
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ASAS 5/6 response rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Partial remission response rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Quality-of-life outcome measures
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Frequencies of patient death
Endpoint domain: Mortality/survival
Primary endpoint: Renal adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Survival at the end of the study
Endpoint domain: Mortality/survival
Primary endpoint: Initiation of delinquent behavior
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean levels of targeted risks
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: abdominal fat reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Recommendation of medication
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: ICIQ-UI-SF score improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: decrease in number of incontinence episodes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area under the plasma time‐concentration curve (AUC(0‐infinity)) of omeprazole
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Ratio of AUC(0‐infinity) of 5‐hydroxyomeprazole to omeprazole
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Composite score of meibum quality and expressibility
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Quantity of Demodex folliculorum
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Symptoms and ocular surface staining
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in brain atrophy (PBVC/y)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Postoperative bone resorption
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: speech recognition in noise
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Undetectable Tg and negative 131I scan
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Disease progression
Endpoint domain: Adverse events/effects
Primary endpoint: Quality of life associated with peripheral vestibulopathy
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Balance relevant to activities of daily living (ADLs)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Skills and knowledge
Endpoint domain: Life impact
Endpoint subdomain: Other resource use
Primary endpoint: survival benefit of platinum-based chemotherapy
Endpoint domain: Mortality/survival
Primary endpoint: clinical efficacy of PKEP
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 6-month amputation rate
Endpoint domain: Mortality/survival
Primary endpoint: Depth of palpation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Duration of examination
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cardiovascular death
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: 5-year risk for incident heart failure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Reduction in diagnostic error
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cognitive change from baseline
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: mean severity score of seborrheic dermatitis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Anatomical occlusion rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: VCSS improvement
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: AVVQ improvement
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in N-terminal pro-brain natriuretic peptide
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cervical length measurements
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Risk of preterm birth
Endpoint domain: Mortality/survival
Primary endpoint: Improvement in bradykinesia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Coagulation index (CI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Saccadic symmetry
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Incidence of clinical amnionitis
Endpoint domain: Adverse events/effects
Primary endpoint: mood and behavioral symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: sleep quantity and quality
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: gait velocity during normal walking
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: gait velocity while talking
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of unplanned extubation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Incidence of propofol injection pain
Endpoint domain: Adverse events/effects
Primary endpoint: Duration of pruritus
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Renal clearance of zidovudine
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Incidence of all-grade gastrointestinal perforations
Endpoint domain: Adverse events/effects
Primary endpoint: Miscarriage rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Efficacy of chamomile extract to remove smear layer
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Fasting LDL cholesterol concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: perception of respiratory sensation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: incidence and severity of chemotherapy-induced mucositis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: occurrence of serious medication errors
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Progression rate to an insulin-dependent state
Endpoint domain: Mortality/survival
Primary endpoint: Preservation of SigmaC-peptide values
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Percentage of clients obtaining competitive employment
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Average hours of competitive work
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: relief of variable decelerations in labor
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: VAS results
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: EBP-K scores
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: EBP-P scores
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Time to recovery of TOF ratio to 0.9
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Mean changes in dyspnea
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Average variable Advance Care Planning costs
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Average costs of medical care
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: HPV series initiation rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Plasma glucose reduction 2 h after breakfast
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Pain-free state within 2 hours of medication administration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Median headache intensity over 24 hours after ED discharge
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of GOR episodes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Duration of GOR episodes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: fasting and postprandial insulin levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: serum vitamin B12 concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Number of coagulase-negative staphylococcal (CONS) bacteremias
Endpoint domain: Adverse events/effects
Primary endpoint: Total number of bacteremias and fungemias
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of infective complications requiring a repeat operation
Endpoint domain: Adverse events/effects
Primary endpoint: Safety and feasibility of autologous AdMSCs infusion
Endpoint domain: Adverse events/effects
Primary endpoint: inflammation in the mucosa and epithelium
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean marginal bone loss below the implant platform
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Plasma concentration of BNP
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Cardio-thoracic ratio (CTR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Caesarean section deliveries
Endpoint domain: Adverse events/effects
Primary endpoint: Serum 17beta‐oestradiol and progesterone concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Influence of comorbidity and age on stage at initial diagnosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Leukopenia grade III/IV
Endpoint domain: Adverse events/effects
Primary endpoint: Catheter-related bloodstream infections (CRBSIs)
Endpoint domain: Adverse events/effects
Primary endpoint: Total bloodstream infections
Endpoint domain: Adverse events/effects
Primary endpoint: Healthcare-associated infections rates
Endpoint domain: Adverse events/effects
Primary endpoint: Hepatic venous pressure gradient mean
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Left renal vein flow
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Cardiac Output (CI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Oxygen Extraction (AO2)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Total lesion lengths (TLL)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: overall weight losses
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: sVCAM-1 concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: sICAM-1 concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Children's BMI percentile
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean urine leakage
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean 72-hour incontinence episodes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: rate of clot resolution
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Duration of supplemental oxygen
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Overall clinical progression
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Acute urinary retention
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: subjective pain reports
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Immunogenicity (PAMVAC-specific antibody levels)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: NP acquisition of additional PCV13 serotypes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Prevalence of NP colonization
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: IgG responses for PCV13 additional serotypes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Dynamic Central Venous Pressure (D(c-i)VP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes